Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.

The HLA complex plays a prominent role in predisposition to many autoimmune diseases. Thus far, the highly polymorphic class I and class II loci have been considered as the prime candidates to explain this role. There is nonetheless growing evidence that other closely linked HLA loci are also involved in autoimmune susceptibility. Their search, however, has been hampered by the often strong linkage disequilibria, i.e. the non-random association of alleles at linked loci, across the HLA complex. Here, we discuss recent work from our laboratory on the dissection of this emblematic genetic region in a model autoimmune disease, acquired myasthenia gravis (MG).

[1]  A. Engel Myasthenia gravis and myasthenic syndromes , 1984, Annals of neurology.

[2]  A. Cambon-Thomsen,et al.  Tumor necrosis factor microsatellites in four European populations. , 1993, Human immunology.

[3]  D Elmqvist Myasthenia Gravis , 1975, The Lancet.

[4]  James T. Elder,et al.  Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. , 2002, American journal of human genetics.

[5]  Y. Yoshikawa,et al.  Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. , 2003, American journal of human genetics.

[6]  Sue Povey,et al.  Gene map of the extended human MHC , 2004, Nature Reviews Genetics.

[7]  R. Hohlfeld,et al.  The role of the thymus in myasthenia gravis. , 1994, Advances in neuroimmunology.

[8]  J. McCluskey,et al.  Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.

[9]  E. G. de la Concha,et al.  MHC Susceptibility Genes to IgA Deficiency Are Located in Different Regions on Different HLA Haplotypes1 , 2002, The Journal of Immunology.

[10]  J. Dausset The Major Histocompatibility Complex in Man , 1992 .

[11]  B. Eymard,et al.  Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. , 2001, Archives of neurology.

[12]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[13]  Tariq Ahmad,et al.  Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. , 2003, Human molecular genetics.

[14]  H. Garchon,et al.  An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. , 2002, Diabetes.

[15]  H. Shin,et al.  Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. , 2004, Human molecular genetics.

[16]  J. Todd,et al.  Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and –DRB1 , 2003, Genes and Immunity.

[17]  Terence Dwyer,et al.  Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. , 2002, American journal of human genetics.

[18]  H. Inoko,et al.  A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. , 2001, Genomics.

[19]  J. Patrick,et al.  Autoimmune Response to Acetylcholine Receptor , 1973, Science.

[20]  F. Christiansen,et al.  An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes , 1992, Immunogenetics.

[21]  D. Drachman Myasthenia Gravis and the Thyroid Gland , 1962 .

[22]  M. Baets,et al.  The role of antibodies in myasthenia gravis , 2002, Journal of the Neurological Sciences.

[23]  A. Cambon-Thomsen,et al.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Garchon,et al.  Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. , 1997, Journal of autoimmunity.

[25]  B. Eymard,et al.  Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies , 2001, Neurology.

[26]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[27]  A. Cambon-Thomsen,et al.  HLA ‐A,‐B,‐DR HAPLOTYPE FREQUENCIES IN FRANCE—IMPLICATIONS FOR RECRUITMENT OF POTENTIAL BONE MARROW DONORS , 1995, Transplantation.

[28]  T. Ogihara,et al.  Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. , 2000, Human immunology.

[29]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[30]  Wei Chen,et al.  Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. , 2002, American journal of human genetics.

[31]  B P Koeleman,et al.  Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. , 2000, Human molecular genetics.

[32]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[33]  P. Christadoss C5 gene influences the development of murine myasthenia gravis. , 1988, Journal of immunology.

[34]  S. Higgs,et al.  Genetic Evidence for Involvement of Classical Complement Pathway in Induction of Experimental Autoimmune Myasthenia Gravis 1 , 2003, The Journal of Immunology.

[35]  P. H. Moghaddam,et al.  Genetic Structure of IDDM1: Two Separate Regions in the Major Histocompatibility Complex Contribute to Susceptibility or Protection , 1998, Diabetes.

[36]  A. Vincent,et al.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. , 1980, Brain : a journal of neurology.

[37]  F. Breedveld,et al.  The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. , 2001, Human immunology.

[38]  C. Caruso,et al.  Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. , 2002, Autoimmunity reviews.

[39]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[40]  E. Thorsby,et al.  Invited anniversary review: HLA associated diseases. , 1997, Human immunology.

[41]  A. Katz,et al.  Genetic prediction of nonresponse to hepatitis B vaccine. , 1989, The New England journal of medicine.

[42]  F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[43]  F. Naeim,et al.  Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. , 1978, Tissue antigens.

[44]  C. Alper GENETIC PREDICTION OF NON-RESPONSE TO HEPATITIS B VACCINE , 1990 .

[45]  I. Tsiropoulos,et al.  Associated autoimmune diseases in myasthenia gravis A population‐based study , 1995, Acta neurologica Scandinavica.

[46]  B. Eymard,et al.  Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci , 2004, Genes and Immunity.

[47]  J. Lindstrom,et al.  Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.

[48]  J. Dausset,et al.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Bunce,et al.  A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. , 1999, Human immunology.

[50]  S. Horowitz,et al.  HL-A ANTIGENS IN MYASTHENIA GRAVIS , 1974 .

[51]  The Chinese Human Genome Sequencing Consortium,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[52]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[53]  A. Salmaggi,et al.  Tumour necrosis factor microsatellite alleles in an Italian population. , 1997, European journal of immunogenetics.

[54]  J. Dausset,et al.  Genetics of HLA disease association. , 1981, Annual review of genetics.

[55]  F. Schuit,et al.  Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. , 1998, Diabetes.